Investment Rating - The report assigns a "Buy" rating for the company [7] Core Views - The company is expected to achieve a net profit attributable to shareholders of RMB 15.8-17.4 billion in 2025, representing a year-on-year increase of 50-65%, which aligns with previous expectations and exceeds market consensus [7] - The company has demonstrated strong growth due to ongoing reforms, with a projected net profit of RMB 16.6 billion for 2025, reflecting a year-on-year increase of 57.5% [7] - The company is focusing on product structure upgrades and expanding its beverage business, which is anticipated to drive future growth [7] Financial Summary - Revenue projections for the company are as follows: - 2023: RMB 14,213 million - 2024: RMB 14,667 million (growth rate: 3.2%) - 2025: RMB 15,319 million (growth rate: 4.4%) - 2026: RMB 16,264 million (growth rate: 6.2%) - 2027: RMB 17,020 million (growth rate: 4.6%) [3] - EBITDA is projected to grow significantly, reaching RMB 3,724 million by 2027 [3] - The net profit attributable to shareholders is expected to increase from RMB 645 million in 2023 to RMB 2,371 million in 2027, with a growth rate of 16.9% in 2027 [3] - The earnings per share (EPS) is projected to rise from RMB 0.23 in 2023 to RMB 0.84 in 2027 [3] - The company’s price-to-earnings (P/E) ratio is expected to decrease from 37.7 in 2023 to 14.9 in 2027, indicating improved valuation [3] Strategic Focus - The company is undergoing comprehensive reforms, with a focus on enhancing its product offerings and operational efficiency, which is expected to lead to improved profit margins [7] - The introduction of the "燕京 U8" product aims to capture the preferences of younger consumers and drive national expansion [7] - The company is also exploring the health food segment with its natto products, indicating a diversification strategy [7]

Core Viewpoint - The company forecasts a net profit attributable to shareholders of 1.58-1.74 billion yuan for 2025, representing a year-on-year increase of 50-65% [1] - The company expects a non-recurring net profit of 1.46-1.56 billion yuan for 2025, indicating a year-on-year growth of 40-50% [1] Group 1: Financial Projections - For 2025, the average forecast for net profit attributable to shareholders is 1.66 billion yuan, reflecting a year-on-year increase of 58% [1] - The expected non-recurring net profit for 2025 is 1.51 billion yuan, showing a year-on-year growth of 45% [1] - Revenue projections for 2025-2027 are 15.34 billion, 15.97 billion, and 16.56 billion yuan, with year-on-year growth rates of 4.6%, 4.1%, and 3.7% respectively [2] Group 2: Profit Drivers - The increase in profits is attributed to land reserve acquisitions by subsidiaries and ongoing internal reforms that enhance profit margins [1] - The company is diversifying its business beyond beer, including ventures into natto and beverages, which is expected to further improve profit margins [1] Group 3: Quarterly Performance - In Q4 2025, the company anticipates a net profit attributable to shareholders of -110 million yuan, a reduction in losses by 120 million yuan year-on-year [1] - The expected non-recurring net profit for Q4 2025 is -180 million yuan, a decrease in losses by 44.58 million yuan year-on-year [1]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 17.25 [1][9]. Core Insights - The company is expected to achieve significant profit growth, with a projected net profit for 2025 ranging from RMB 1.58 billion to RMB 1.74 billion, representing a year-on-year increase of 50% to 65% [6]. - The company anticipates a reduction in losses for Q4 2025 compared to Q4 2024, driven by land reserve contributions and operational improvements [6]. - The U8 product line is expected to continue its rapid growth, supported by strategic market expansions and new product launches at a price point of RMB 10 [7][9]. Financial Performance and Forecast - Revenue projections for the company are as follows: RMB 14.67 billion in 2024, RMB 15.14 billion in 2025, RMB 15.48 billion in 2026, and RMB 15.84 billion in 2027, with growth rates of 3.20%, 3.24%, 2.25%, and 2.32% respectively [5]. - The net profit attributable to the parent company is forecasted to be RMB 1.06 billion in 2024, RMB 1.68 billion in 2025, RMB 1.95 billion in 2026, and RMB 2.25 billion in 2027, with growth rates of 63.74%, 59.29%, 16.09%, and 15.12% respectively [5]. - The company’s EPS is projected to increase from RMB 0.37 in 2024 to RMB 0.80 in 2027 [5]. Valuation Metrics - The company’s PE ratio is expected to decrease from 33.40 in 2024 to 15.69 in 2027, indicating an improving valuation as earnings grow [5]. - The target price of RMB 17.25 corresponds to a PE of 25x for 2026, reflecting a higher growth rate compared to peers [9][10]. Market Position and Strategy - The company is focusing on optimizing its product structure and reducing costs, which is expected to enhance profit margins [8]. - The beverage business is anticipated to contribute significantly to revenue growth, particularly in core markets [7]. - The company is also benefiting from trends towards health-conscious products, particularly in its natto business [7].

1、如何看待Q4减亏？ 25Q4土地收储贡献5700万利润，中值计算25Q4经营性利润/扣非归母减亏了6717万/4458万元，考虑到24Q4公司营 业外支出高达4342万元、23Q4/22Q4仅为390/64万元，我们认为燕京依然具备较大的利润释放空间，或因25Q4收 入端并未享受春节备货红利，#26Q1开门红值得期待，再次强调燕京啤酒作为国企是兼具开门红意愿与能力的企 业； 2025年公司预计实现归母净利润15.8-17.4亿元，同比+50-65%，实现扣非归母净利润14.6-15.6亿元，同比+40- 50%； 2025年实现归母净利润16.6亿元、同比+57.5%，实现扣非归母净利润15.1亿元，同比+45%； 25Q4单季度归母净利润-1.1亿元，同比减亏1.2亿，实现扣非归母净利润-1.8亿元，同比减亏4458万元。 【广发食品】燕京啤酒2025年业绩预告点评 2025年公司预计实现归母净利润15.8-17.4亿元，同比+50-65%，实现扣非归母净利润14.6-15.6亿元，同比+40- 50%； 2025年实现归母净利润16.6亿元、同比+57.5%，实现扣非归母净利润15.1亿元，同比+45 ...

中证智能财讯青岛啤酒（600600）1月21日公告，公司董事会审议通过，同意全资子公司青岛啤酒财务 有限责任公司使用自有资金开展2026年度固定收益类投资业务，任一业务时点的投资余额合计不超过 43.4亿元且不超过财务公司资本净额的70%，额度内资金可滚动使用，有效期自董事会审议通过之日起 12个月内。 青岛啤酒主要业务为生产和销售啤酒等产品。2025年前三季度，公司实现营业总收入293.67亿元，同比 增长1.41%；归母净利润52.74亿元，同比增长5.70%。 （文章来源：中国证券报·中证网） 公告显示，本次投资品种包括国债、地方政府债券、金融债券、AAA级企业债券、货币市场基金和固 定收益类基金，受托方为信誉佳的金融机构。财务公司将通过建立投资台账、制定相关管理制度及接受 内外部审计监督等方式控制风险。 公司表示，此举是为提高资金利用效率与现金资产收益，不影响主营业务发展。 ...

Group 1: Consumer Confidence and Market Trends - UBS believes that consumer confidence is improving, with a notable shift in preferences among consumers [3] - The firm conducted discussions with approximately 35 consumer companies and observed a recovery in consumer sentiment despite a short-term downturn in the real estate market [3] - UBS indicates that the valuation of the consumer sector remains attractive, being about one standard deviation below the 10-year average, and has not yet reflected the recovery in consumption [3] Group 2: Sector-Specific Insights - The snack industry is expected to benefit from category expansion and channel restructuring, presenting structural growth opportunities [6] - In the liquor sector, private consumption and potential easing of drinking bans for government institutions may support mid-range liquor demand, with companies accelerating channel transformation for sustainable long-term earnings growth [5] - The ready-to-drink beverage (FMB) segment is projected to capture market share from bottled beverages, driven by rapid store expansion and more efficient business models [5] Group 3: Dairy and Other Beverages - Despite resilience in fresh milk, liquid milk sales are expected to remain weak in 2025, with a slight recovery anticipated in 2026 due to improved raw milk supply and demand, alongside marketing and innovation efforts [5] - The beer segment is experiencing short-term consumption fatigue, but product diversification and home consumption channel expansion continue to drive premiumization [5] Group 4: Other Consumer Goods - The pet food sector shows confidence in domestic market growth despite varying overseas growth prospects [7] - The home appliance industry is expected to see higher growth overseas compared to the domestic market, with strategies to cope with rising material costs differing among companies [9] - In the jewelry sector, brands with differentiated product designs and craftsmanship may pursue consolidation following VAT reforms [10]

北京控股（00392）公布，燕京啤酒（000729.SZ）预期2025年归母净利为约15.835亿-17.42亿元，同比 增长50%-65%；扣除非经常性损益后的净利润约14.57亿-15.61亿元，同比增长40%-50%。 报告期内，燕京啤酒（000729.SZ）坚定推进大单品战略，围绕产品力、品牌力、渠道力积极探寻创新 路径，深化卓越管理体系建设，推行品牌年轻化、时尚化、高端化建设，实施梯度化市场开发策略，燕 京 U8 继续保持稳健增长态势。燕京啤酒（000729.SZ）持续攻坚生产、营销、市场和供应链等关键业 务领域变革，扎实推进各项战略举措，强健组织机制保障，以产品升级、市场升级和管理升级，全面提 升管理质效，系统激活运营效率和增长潜力，企业经营效益持续向好。 2025 年度非经常性损益主要系燕京啤酒（000729.SZ）确认了子公司土地收储款，增加归母净利润约 1.32 亿元。 责任编辑：卢昱君 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 北京控股（00392）公布，燕京啤酒（000729.SZ）预期2025年归母净利为约15.835亿-17.42亿元，同比 增长50%-65% ...

Core Viewpoint - The company expects a significant increase in net profit for the year 2025, driven by both core business performance and non-recurring gains [1][3]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025, with an expected net profit that is positive and indicates a growth trend [1]. - The company has communicated with its accounting firm regarding the preliminary financial data, which has not yet been audited, and there are no significant disagreements [1][2]. Group 2: Business Impact - The company is actively pursuing a major product strategy, focusing on product strength, brand power, and channel capabilities, while implementing innovative paths and enhancing management systems [2]. - The company aims for brand rejuvenation, modernization, and premiumization, alongside a tiered market development strategy, with the Yanjing U8 product line showing steady growth [2]. Group 3: Non-Recurring Gains - The non-recurring gains for the year 2025 primarily stem from the recognition of land reserve payments from a subsidiary, which is expected to increase net profit attributable to shareholders by approximately 132 million yuan [3]. - The overall expected net profit growth compared to the previous year is projected to be between 50.00% and 65.00% [3].

Group 1 - The company held its 4th meeting of the 11th Board of Directors on January 19, 2026, with all 9 directors present, complying with legal and regulatory requirements [2][4] - The Board approved the financial company's fixed income investment plan for 2026, allowing investments up to RMB 4.34 billion, not exceeding 70% of the financial company's net capital [3][14] - The investment will include government bonds, financial bonds, AAA-rated corporate bonds, money market funds, and fixed income funds, with a validity period of 12 months from the approval date [15][18] Group 2 - The Board approved the appointment of Mr. Wang Yan as Vice President, effective immediately until the end of the current Board's term [5][6] - The Board also approved daily related party transactions with Qingdao Beer Group and its subsidiaries, with an estimated total transaction amount of RMB 1,342.89 million for 2026 [6][30] - The related party transactions include various framework agreements for production, sales, and service provisions, which are deemed to be conducted under normal commercial terms [30][31] Group 3 - The company will engage in daily related party transactions with Qingdao Beverage Group, Qingdao Youjia Health Beverage Co., and others, with specific agreements signed on January 20, 2026 [28][47] - The total expected transaction amount for the framework agreements is capped at RMB 41.5 million for the production and sales services, and RMB 123.9 million for supply chain services [52][59] - The agreements are structured to ensure fair pricing and compliance with market standards, with independent directors confirming the fairness of the transactions [34][45]

Group 1: Earnings Forecasts - Huabang Health expects a net profit of 660 million to 730 million yuan for 2025, recovering from a loss of 299 million yuan in the previous year, driven by improvements in its agricultural chemical materials sector and steady growth in its pharmaceutical and tourism segments [2] - Kangda New Materials anticipates a net profit of 125 million to 135 million yuan for 2025, compared to a loss of 246 million yuan last year, primarily due to significant sales growth in adhesive and specialty resin products, particularly in the wind power sector [2] - Longxin Technology forecasts a net profit of 100 million to 150 million yuan for 2025, recovering from a loss of 250 million yuan, with improvements in its energy digitalization business and reduced losses in its new energy sector [3] - Hualu Bio expects a net profit of 100 million to 130 million yuan for 2025, recovering from a loss of 47.57 million yuan, attributed to increases in both sales price and volume [3] - Jiuxi Software predicts a net profit of 40 million to 60 million yuan for 2025, recovering from a loss of 156 million yuan, supported by AI technology enhancements and market expansion strategies [3] Group 2: Major Corporate Developments - Liou Co. has completed its stock suspension review and will resume trading on January 21, 2026, confirming that its business operations remain normal and no significant undisclosed matters exist [4] - Hikvision reported total revenue of 92.518 billion yuan for 2025, a slight increase of 0.02%, with a net profit of 14.188 billion yuan, up 18.46%, driven by strategic adjustments and improved cash flow management [6] - JianTou Energy expects a net profit of approximately 1.877 billion yuan for 2025, a significant increase of about 253.38% from the previous year, due to optimized coal resource allocation and cost management [6] Group 3: Investment and Mergers - Aibo Medical plans to acquire at least 51% of Demai Medical to gain control, aiming to leverage its R&D advantages in the sports health sector [19] - Yifan Transmission intends to purchase 87.07% of Beijing Helishi Motor Technology Co., which will become a subsidiary upon successful completion of the transaction [16] - Guangdong Hongtu plans to invest up to 95 million yuan to establish a subsidiary in Thailand for automotive parts production and sales [20] Group 4: Stock Performance and Changes - Huicheng Environmental's major shareholder plans to increase their stake in the company by investing between 25 million and 50 million yuan within six months [22] - Liou Co. will resume trading after completing its stock suspension review, indicating stability in its operations [24] - Kailong High-Tech and Debang Co. have been suspended from trading, indicating potential issues or developments requiring further clarification [25]